el-Dahr S S, Figueroa C D, Gonzalez C B, Müller-Esterl W
Section of Pediatric Nephrology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Kidney Int. 1997 Mar;51(3):739-49. doi: 10.1038/ki.1997.105.
Kinins modulate renal function, yet their role in the developing kidney is largely unknown. To explore the developmental role of the kallikrein-kinin system, we examined the postnatal ontogeny and intrarenal localization of B2 receptors in the rat. Northern blot analysis and RT-PCR documented the expression of B2 receptor mRNA in the kidney and extrarenal tissues of fetal, neonatal and adult animals. The abundance of B2 receptor mRNA is 10- to 30-fold higher in neonatal than adult tissues in the following order: kidney > heart > aorta > lung > brain. Receptor autoradiography revealed a gradual shift in the localization of bradykinin binding sites from the outer cortex in the newborn to the outer medulla in weanling and maturing rats. The almost complete displacement of [125I]tyr(zero)-bradykinin by HOE-140 indicates that the majority of kinin receptors in the developing kidney belong to the B2 type. Immunolocalization studies using antipeptide antibodies directed against various portions of the receptor revealed that B2 receptors are first expressed on the luminal aspect of the upper limb of S-shaped bodies and differentiating cortical collecting ducts. In marked contrast, the metanephric mesenchyme, pretubular aggregates and glomeruli display weak or no B2 receptor immunoreactivity. Following completion of nephrogenesis, B2 receptor expression shifts to both luminal and basolateral aspects of connecting tubules and collecting ducts. The results demonstrate that bradykinin B2 receptor gene expression is activated in the developing kidney and cardiovascular system. The spatially restricted expression of B2 receptors in the differentiating epithelium of the distal nephron, the site of kinin formation, supports the hypothesis that kinins are paracrine modulators of segmental nephron maturation.
激肽可调节肾功能,但其在发育中的肾脏中的作用尚不清楚。为了探究激肽释放酶 - 激肽系统的发育作用,我们检测了大鼠出生后B2受体的个体发育及肾内定位。Northern印迹分析和逆转录 - 聚合酶链反应(RT-PCR)证实了胎儿、新生儿和成年动物的肾脏及肾外组织中B2受体mRNA的表达。新生儿组织中B2受体mRNA的丰度比成年组织高10至30倍,顺序如下:肾脏>心脏>主动脉>肺>脑。受体放射自显影显示,缓激肽结合位点的定位从新生大鼠的外皮质逐渐转移到断奶和成熟大鼠的外髓质。HOE-140几乎完全取代[125I]tyr(0)-缓激肽,表明发育中的肾脏中的大多数激肽受体属于B2型。使用针对受体不同部分的抗肽抗体进行的免疫定位研究表明,B2受体首先在S形小体上肢和分化中的皮质集合管的管腔面表达。与之形成鲜明对比的是,后肾间充质、肾小管前聚集体和肾小球显示出弱的B2受体免疫反应性或无免疫反应性。肾发生完成后,B2受体表达转移至连接小管和集合管的管腔面和基底外侧。结果表明,缓激肽B2受体基因表达在发育中的肾脏和心血管系统中被激活。B2受体在远端肾单位分化上皮(激肽形成部位)中的空间限制性表达支持了激肽是节段性肾单位成熟的旁分泌调节剂这一假说。